What execs and experts think of the future of drug costs.
Learning a patient's specific situation might help overcome adherence barriers.
Drug shortages might be decreasing, but their continued existence is urging the pharmacy industry to maintain its vigilance.
How you can manage these stereotypes found in the pharmacy workplace.
Oncologists recognize the potential of artificial intelligence (AI) in improving the quality of care and patient outcomes according to new research.
Across the country, minority populations face significant disparities in medication use. It's time for that to change.
Vabomere combines a carbapenem and a beta-lactamase inhibitor as a treatment for complicated urinary tract infections.
Up to 30% of the population is affected by the problem, this peer-reviewed article will give you the information you need.
Melphalan flufenamide (Pepaxto; Oncopeptides AB) in combination with dexamethasone was granted accelerated approval on February 26, 2021, by the FDA for adult patients with relapsed or refractory multiple myeloma.
Here: an overview of atezolizumab, the first new drug in two decades for bladder cancer and now approved for NSCLC.
Greater accountability for pharmacy benefit managers? That's just one of the goals of the President of the National Community Pharmacists Association.
Pharmacists must find good alternative therapeutic substitutions for sodium nitroprusside in the face of price gouging and drug shortages.
The pharmacist's role in diabetes care will only continue to grow.
A look at the ways coaching your patients can leave them healthier.
Owners can use the cash accounting method to optimize tax savings.
Patients seeking OTC remedies for asthma should be counseled on the risks associated with OTC asthma products.
A drug underdevelopment may provide another pathway to lowering LDL levels.
A closer look at how recent innovations are shaping how pharmacists and patients interact-for the better.
Our annual pick of the worst states to practice pharmacy in America is back with the 2018 results.
How can we better engage patients for greater adherence rates?